The Preclinical Efficacy Of Ketogenic Diet In IDH1 Wild-type And Mutant Gliomas

被引：0
|
作者：
Javier, Rodrigo [1 ]
Mirkov, Snezana [1 ]
Horbinski, Craig [1 ]
机构：
[1] Northwestern Univ, Evanston, IL 60208 USA
来源：
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY | 2020年 / 79卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
50
引用
收藏
页码：667 / 667
页数：1
相关论文
共 50 条
  • [31] Nuclear Exclusion of TET1 Is Associated with Loss of 5-Hydroxymethylcytosine in IDH1 Wild-Type Gliomas
    Mueller, Tim
    Gessi, Marco
    Waha, Anke
    Isselstein, Lukas Jan
    Luxen, Daniel
    Freihoff, Dorothee
    Freihoff, Johannes
    Becker, Albert
    Simon, Matthias
    Hammes, Jennifer
    Denkhaus, Dorota
    zur Muehlen, Anja
    Pietsch, Torsten
    Waha, Andreas
    AMERICAN JOURNAL OF PATHOLOGY, 2012, 181 (02): : 675 - 683
  • [32] DZIP3 is a key factor to stratify IDH1 wild-type lower-grade gliomas
    Liang, Tingyu
    Zhou, Xingang
    Li, Peiliang
    You, Gan
    Wang, Fang
    Wang, Peng
    Feng, Enshan
    AGING-US, 2020, 12 (24): : 24995 - 25004
  • [33] OPTIMIZATION OF DEMETHYLATING THERAPY FOR IDH1 MUTANT GLIOMAS
    Riggins, Gregory J.
    Borodovsky, Alexandra
    NEURO-ONCOLOGY, 2014, 16
  • [34] Targeting wild-type IDH1 enhances chemosensitivity in pancreatic cancer
    Zarei, Mehrdad
    Hajihassani, Omid
    Hue, Jonathan J.
    Graor, Hallie J.
    Hajihassani, Arian
    Loftus, Alexander W.
    Rothermel, Luke D.
    Winter, Jordan M.
    CANCER RESEARCH, 2023, 83 (07)
  • [35] Wild-type IDH1 inhibition enhances chemotherapy response in melanoma
    Zarei, Mehrdad
    Hajihassani, Omid
    Hue, Jonathan J.
    Graor, Hallie J.
    Loftus, Alexander W.
    Rathore, Moeez
    Vaziri-Gohar, Ali
    Asara, John M.
    Winter, Jordan M.
    Rothermel, Luke D.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [36] METABOLIC IMAGING BIOMARKERS FOR MUTANT IDH1 GLIOMAS
    Ronen, Sabrina M.
    Izquierdo-Garcia, Jose L.
    Chaumeil, Myriam M.
    Cai, Larry M.
    Phillips, Joanna J.
    Pieper, Russell O.
    NEURO-ONCOLOGY, 2014, 16
  • [37] Wild-type and mutated IDH1/2 enzymes and therapy responses
    Remco J. Molenaar
    Jaroslaw P. Maciejewski
    Johanna W. Wilmink
    Cornelis J. F. van Noorden
    Oncogene, 2018, 37 : 1949 - 1960
  • [38] Wild-type and mutated IDH1/2 enzymes and therapy responses
    Molenaar, Remco J.
    Maciejewski, Jaroslaw P.
    Wilmink, Johanna W.
    van Noorden, Cornelis J. F.
    ONCOGENE, 2018, 37 (15) : 1949 - 1960
  • [39] Wild-type IDH1 inhibition enhances chemotherapy response in melanoma
    Mehrdad Zarei
    Omid Hajihassani
    Jonathan J. Hue
    Hallie J. Graor
    Alexander W. Loftus
    Moeez Rathore
    Ali Vaziri-Gohar
    John M. Asara
    Jordan M. Winter
    Luke D. Rothermel
    Journal of Experimental & Clinical Cancer Research, 41
  • [40] BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1
    Toenjes, Martje
    Barbus, Sebastian
    Park, Yoon Jung
    Wang, Wei
    Schlotter, Magdalena
    Lindroth, Anders M.
    Pleier, Sabrina V.
    Bai, Alfa H. C.
    Karra, Daniela
    Piro, Rosario M.
    Felsberg, Joerg
    Addington, Adele
    Lemke, Dieter
    Weibrecht, Irene
    Hovestadt, Volker
    Rolli, Claudio G.
    Campos, Benito
    Turcan, Sevin
    Sturm, Dominik
    Witt, Hendrik
    Chan, Timothy A.
    Herold-Mende, Christel
    Kemkemer, Ralf
    Koenig, Rainer
    Schmidt, Kathrin
    Hull, William-Edmund
    Pfister, Stefan M.
    Jugold, Manfred
    Hutson, Susan M.
    Plass, Christoph
    Okun, Juergen G.
    Reifenberger, Guido
    Lichter, Peter
    Radlwimmer, Bernhard
    NATURE MEDICINE, 2013, 19 (07) : 901 - +
12345